Biomaterial Database

Quinolone resistance mechanisms in Klebsiella pneumoniae. 1995

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Department of Infectious Diseases, First Affiliated Hospital, Chongqing University of Medical Sciences, China.

UI	MeSH Term	Description	Entries
D007711	Klebsiella pneumoniae	Gram-negative, non-motile, capsulated, gas-producing rods found widely in nature and associated with urinary and respiratory infections in humans.	Bacillus pneumoniae,Bacterium pneumoniae crouposae,Hyalococcus pneumoniae,Klebsiella pneumoniae aerogenes,Klebsiella rhinoscleromatis
D009154	Mutation	Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations.	Mutations
D002939	Ciprofloxacin	A broad-spectrum antimicrobial carboxyfluoroquinoline.	Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004250	DNA Topoisomerases, Type II	DNA TOPOISOMERASES that catalyze ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands. These enzymes bring about relaxation of the supercoiled DNA and resolution of a knotted circular DNA duplex.	DNA Topoisomerase (ATP-Hydrolysing),DNA Topoisomerase II,DNA Topoisomerase II alpha,DNA Topoisomerase II beta,DNA Type 2 Topoisomerase,TOP2A Protein,TOP2B Protein,Topoisomerase II,Topoisomerase II alpha,Topoisomerase II beta,Type II DNA Topoisomerase,alpha, Topoisomerase II,beta, Topoisomerase II
D000890	Anti-Infective Agents	Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection.	Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001425	Bacterial Outer Membrane Proteins	Proteins isolated from the outer membrane of Gram-negative bacteria.	OMP Proteins,Outer Membrane Proteins, Bacterial,Outer Membrane Lipoproteins, Bacterial

Related Publications

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.

January 2000, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Complement resistance mechanisms of Klebsiella pneumoniae.

October 2016, Immunobiology,

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Discovery of a Klebsiella pneumoniae isolate with multiple quinolone-resistant mechanisms in China.

October 2010, The Journal of hospital infection,

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Characterization of Transferrable Mechanisms of Quinolone Resistance (TMQR) among Quinolone-resistant Escherichia coli and Klebsiella pneumoniae causing Urinary Tract Infection in Nepalese Children.

September 2023, BMC pediatrics,

Y H Xiao, and A Kitamura, and K Hoshino, and K Sato

Molecular basis of quinolone resistance in clinical isolates of Klebsiella pneumoniae from Pakistan.

July 2018, Pakistan journal of pharmaceutical sciences,